Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-18 @ 8:13 AM
Ignite Modification Date:
2025-12-18 @ 8:13 AM
NCT ID:
NCT05846724
Brief Title:
Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma
Official Title:
A Phase II Single-arm Study of Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma (CKS)
Acronym:
PULSAR
Study:
NCT05846724
Protocol Section:
NCT05846724